Observational studyJAMA network open2022

Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).

Jordana B Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.